Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
📅 Plan for Wealth: Key market movers that could make (or break) your week
See Economic Calendar
Sarepta Therapeutics Inc (SRPT)
Add to/Remove from a Portfolio
Add to Watchlist
23.26
+0.62
+2.74%
06/10 - Closed. Currency in USD
After Hours
23.35
+0.10
+0.43%
1:16:50 - Real-time Data
Type:
Equity
Market:
United States
- Volume: 6,171,963
- Bid/Ask: 0.00 / 0.00
- Day's Range: 22.31 - 23.59
Sarepta
23.26
+0.62
+2.74%
- Discussions
- Recent Sentiments
- User Rankings
SRPT User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Sarepta Therapeutics Inc share.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Ross Keiser | 3 | 3 | 2 | 66.67 | +76.18% |
| 2 | Wojciech Stefaniak | 1 | 1 | 1 | 100 | +69.17% |
| 3 | Vladimir Yevtushenko | 3 | 3 | 3 | 100 | +59.69% |
| 4 | Gabriel font | 1 | 1 | 1 | 100 | +47.39% |
| 5 | Robert Gysemans | 1 | 1 | 1 | 100 | +32.95% |
| 6 | Pocket Miner | 1 | 1 | 1 | 100 | +31.19% |
| 7 | Kursad Tosun | 3 | 3 | 2 | 66.67 | +30.67% |
| 8 | forexer gerigeldi | 4 | 4 | 2 | 50 | +27.39% |
| 9 | Christopher Tomlinson | 2 | 2 | 2 | 100 | +19.27% |
| 10 | Joan Cochs | 1 | 1 | 1 | 100 | +17.84% |
| 11 | Gidi Reani | 1 | 1 | 1 | 100 | +15.28% |
| 12 | Jorge Pina | 3 | 3 | 2 | 66.67 | +14.22% |
| 13 | Franco Schintu | 1 | 1 | 1 | 100 | +13.97% |
| 14 | Alon Haber | 3 | 3 | 2 | 66.67 | +12.55% |
| 15 | 1 | 1 | 1 | 100 | +12.38% | |
| 16 | Александр Грозный | 1 | 1 | 1 | 100 | +12.07% |
| 17 | Сергей Иванов | 1 | 1 | 1 | 100 | +11.67% |
| 18 | Johann Rheeder | 1 | 1 | 1 | 100 | +10.91% |
| 19 | Marco Oprandi | 2 | 2 | 2 | 100 | +10.73% |
| 20 | דורון מולה | 1 | 1 | 1 | 100 | +10.6% |
| 21 | DON DIEGO | 1 | 1 | 1 | 100 | +10.58% |
| 22 | antonio spiezia | 1 | 1 | 1 | 100 | +9.65% |
| 23 | Nicolas Ardusso | 2 | 2 | 1 | 50 | +9.58% |
| 24 | luis cabral | 1 | 1 | 1 | 100 | +9.43% |
| 25 | Samuel Pérez Marante | 1 | 1 | 1 | 100 | +9.32% |
| 26 | Christian Medina Esteban | 1 | 1 | 1 | 100 | +9.23% |
| 27 | Boroda Крылов | 1 | 1 | 1 | 100 | +9.06% |
| 28 | Samuel Galvano | 1 | 1 | 1 | 100 | +8.05% |
| 29 | Nando Recio Vivar | 1 | 1 | 1 | 100 | +7.94% |
| 30 | ritchie donaghue | 3 | 3 | 2 | 66.67 | +7.8% |
| 31 | Drilon Hametaj | 1 | 1 | 1 | 100 | +6.38% |
| 32 | Enrique Lucas | 1 | 1 | 1 | 100 | +5.44% |
| 33 | George Chilton | 1 | 1 | 1 | 100 | +4.45% |
| 34 | Alex Kolesnikov | 3 | 3 | 1 | 33.33 | +3.36% |
| 35 | Ayan Goswami | 1 | 1 | 1 | 100 | +2.58% |
| 36 | Денис Ишуткин | 1 | 1 | 1 | 100 | +2.36% |
| 37 | ritchie donaghue | 3 | 3 | 2 | 66.67 | +2.24% |
| 38 | Oscar Mazzarello | 1 | 1 | 1 | 100 | +1.99% |
| 39 | Mario Rossi | 1 | 0 | 0 | 0 | +1.73% |
| 40 | artur reiter | 1 | 1 | 1 | 100 | +1.63% |
| 41 | jm landaluce | 2 | 2 | 2 | 100 | +1.57% |
| 42 | John Odonoghue | 1 | 1 | 1 | 100 | +1.31% |
| 43 | Mahmoud Sarhan | 1 | 1 | 1 | 100 | +0.55% |
| 44 | Zohaib Hassan | 2 | 2 | 1 | 50 | +0.46% |
| 45 | Hermann Albrecht | 1 | 1 | 1 | 100 | +0.39% |
| 46 | Rocco Paradiso | 1 | 1 | 1 | 100 | +0.32% |
| 47 | Gonçalo Nunes | 1 | 1 | 0 | 0 | -0.13% |
| 48 | ofer av | 1 | 1 | 0 | 0 | -0.31% |
| 49 | Franco Franco | 1 | 1 | 0 | 0 | -0.43% |
| 50 | Chinh Dao | 1 | 1 | 0 | 0 | -0.68% |
Write your thoughts about Sarepta Therapeutics Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review